These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 991145)

  • 21. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
    Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin and chemotherapy in the management of inoperable lung carcinoma.
    Elias EG; Shukla SK; Mink IB
    Cancer; 1975 Jul; 36(1):129-36. PubMed ID: 1203841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Kinetic patterns of changes in the number of peripheral blood leukocytes in lung cancer patients after treatment with cyclophosphane combined with cystaphos].
    Disvetova VV; Levitin EI; Trakhtenberg AKh; Batinov IN
    Izv Akad Nauk SSSR Biol; 1977; (3):351-6. PubMed ID: 886069
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of nonresectable cancer of the lung with hydroxyurea (NSC-32065) given intermittently.
    Kaung DT; Sbar S; Patno ME
    Cancer Chemother Rep; 1971 Feb; 55(1):87-9. PubMed ID: 5121655
    [No Abstract]   [Full Text] [Related]  

  • 25. [Role of bronchological study in the evaluation of the immediate effect of chemotherapy of lung cancer].
    Mamontov AS; Trakhtenberg AKh; Batinov IN; Shishkina RD
    Sov Med; 1973 Jul; 36(7):85-90. PubMed ID: 4776715
    [No Abstract]   [Full Text] [Related]  

  • 26. Immediate cerebral symptoms during rapid intravenous administration of cyclophosphamide (NSC-26271).
    Tashima CK
    Cancer Chemother Rep; 1975; 59(2 Pt 1):441-2. PubMed ID: 1149012
    [No Abstract]   [Full Text] [Related]  

  • 27. [Two cases of neoplasms not justified for classical therapy, treated with intravenous injections of heparin and intramuscular injections of leech extracts].
    ALBERT-WEIL J; NEHORIAS J
    Rev Pathol Gen Physiol Clin; 1954 Jul; 54(660):1014-20. PubMed ID: 13204989
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cyclophosphan treatment of patients with cancer of the lungs].
    Erusalimskiĭ EL
    Vrach Delo; 1972 Aug; 8():108-10. PubMed ID: 5073151
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent advances in the treatment of cancer.
    Knock FE
    IMJ Ill Med J; 1967 Feb; 131(2):192-7 passim. PubMed ID: 4382885
    [No Abstract]   [Full Text] [Related]  

  • 30. [OBSERVATIONS AND RESULTS OF TREATMENT WITH CYCLOPHOSPHAMIDE IN 45 CASES OF LUNG CANCER].
    GRASSI F; SCOCCIA S; TANSINI G
    G Ital Chemioter; 1964; 11():135-43. PubMed ID: 14279688
    [No Abstract]   [Full Text] [Related]  

  • 31. Commentary: To Bleed or to Breathe? Never a Time to Die.
    Litle VR
    Semin Thorac Cardiovasc Surg; 2020; 32(2):345-346. PubMed ID: 32061887
    [No Abstract]   [Full Text] [Related]  

  • 32. Discussion.
    Semin Thorac Cardiovasc Surg; 2020; 32(2):343-344. PubMed ID: 31857152
    [No Abstract]   [Full Text] [Related]  

  • 33. Parenteral anticoagulation in ambulatory patients with cancer.
    Akl EA; Kahale LA; Hakoum MB; Matar CF; Sperati F; Barba M; Yosuico VED; Terrenato I; Synnot A; Schünemann H
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD006652. PubMed ID: 28892556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth.
    Fannon M; Forsten-Williams K; Nugent MA; Gregory KJ; Chu CL; Goerges-Wildt AL; Panigrahy D; Kaipainen A; Barnes C; Lapp C; Shing Y
    J Cell Physiol; 2008 May; 215(2):434-41. PubMed ID: 18163458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulants and experimental metastases-evaluation of antimetastatic effects in different model systems.
    Maat B; Hilgard P
    J Cancer Res Clin Oncol; 1981; 101(3):275-83. PubMed ID: 7309780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of the arrest of hematogenously disseminated tumor cells.
    Tsubura E; Yamashita T; Sone S
    Cancer Metastasis Rev; 1983; 2(3):223-37. PubMed ID: 6367967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal haemostasis in small cell lung cancer.
    Milroy R; Douglas JT; Campbell J; Carter R; Lowe GD; Banham SW
    Thorax; 1988 Dec; 43(12):978-81. PubMed ID: 2467397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulants in the treatment of small cell carcinoma of the bronchus.
    Stanford CF
    Thorax; 1979 Feb; 34(1):113-6. PubMed ID: 375459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trial of heparin and cyclophosphamide (NSC-26271) in the treatment of lung cancer.
    Edlis HE; Goudsmit A; Brindley C; Niemetz J
    Cancer Treat Rep; 1976 May; 60(5):575-8. PubMed ID: 991145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial.
    Lloyd RE; Jones SE; Salmon SE; Durie BG; McMahon LJ
    Cancer Treat Rep; 1976 Jan; 60(1):77-83. PubMed ID: 1000520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.